drugset / Trial / NCT02271919

Varenicline and Combined NRT for Smoking Cessation

NCT02271919

RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized pilot phase IV trial studies the side effects and how well varenicline works compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine replacement therapy consists of nicotine patches and lozenges. It is not yet known if varenicline is more effective than nicotine replacement therapy in helping patients quit smoking.

Timeline

Start
2015-05-14
Primary completion
2025-06-30
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg Oral
Subject Nicotine Patch Unknown 21 mg Other
Subject Nicotine Patch Unknown 42 mg Other
Subject Varenicline Small molecule 2 mg Oral
Subject Varenicline Small molecule 3 mg Oral

Indications